Sam Rasty News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulation...

Investegate announcements from Oxford Biomedica PLC, 2021 Annual report and accounts & AGM notification

PlateletBio trails Sanofi among others in pursuit of a new therapy for a rare blood clotting disorder that has few treatments. But the biotech startup could stand apart from those drugs with its new class of cell therapy, which harnesses the properties of platelets.

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional bod...

  London, UK - 27 April 2021: Oxford Biomedica plc ("Oxford Biomedica", "the Company" or "the Group") (LSE:OXB), a leading gene and cell therapy group, gives notice that copies of the 2020 Annual report and accounts and the Notice of Annual General Meeting ("AGM") have been sent to shareholders. These documents are available on the "Investors" section of the Group's website at www.oxb.com . Oxford Biomedica plc announced its preliminary results for the year ended 31 December 2020 on 15 April 2021. Copies of these documents have been submitted to the Fi...